Xinping Zhang

6.3k citations
62 papers · 5.2k indexed · 1 hit paper · h-index 35

Xinping Zhang

61 papers receiving 5.1k citations

Hit Papers

Cyclooxygenase-2 regulates mesenchymal cell differentiati...5542002202620102018100200300400500

Peers

Xinping Zhang
Comparison fields: 5 of 131
  • Genetics 684
  • Urology 364
  • Rheumatology 827
  • Orthopedics and Sports Medicine 455
  • Biomaterials 634
Replace Xinli Zhang with:
Xinli Zhang United States
Xuenong Zou China
Shiwu Dong China
Cody Bünger Denmark
Herman S. Cheung United States
Marco N. Helder Netherlands
Gary Balian United States
L. C. Gerstenfeld United States
Behrouz Zandieh‐Doulabi Netherlands
Chia Soo United States
Xinping Zhang relative to Xinli Zhang United States Xinli Zhang's profile →
Citations per field
00.5×1.5×
Xinli Zhang · 1×
Citations per year

Countries citing papers authored by Xinping Zhang

Since Specialization
Citations

This map shows the geographic impact of Xinping Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinping Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinping Zhang more than expected).

Fields of papers citing papers by Xinping Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinping Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinping Zhang. The network helps show where Xinping Zhang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xinping Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xinping Zhang Line = papers co-authored together Xinping Zhang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20251
3 20228
4 202160
5 202120
6 202018
7 201926
8 2016173
9 2012194
10 201070
11 2010199
12 200814
13 200815
14 2007114
15 200631
16 2005231
17 200424
18 200498
19 2002494
20 2002102

About Xinping Zhang

Xinping Zhang is a scholar working on Pharmacology, Rheumatology and Genetics, having authored 62 papers that have together received 5.2k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (17 papers), Inflammatory mediators and NSAID effects (14 papers), Bone Tissue Engineering Materials (12 papers), Orthopaedic implants and arthroplasty (11 papers), Bone health and treatments (11 papers), Osteoarthritis Treatment and Mechanisms (8 papers), Bone fractures and treatments (8 papers) and Tissue Engineering and Regenerative Medicine (7 papers). The work is most often cited by research in Genetics (684 citations), Urology (364 citations) and Rheumatology (827 citations). Xinping Zhang has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Regis J. O’Keefe, Edward M. Schwarz, Donald A. Young, J. Edward Puzas, Randy N. Rosier, Chao Xie, Robert E. Guldberg, Hani A. Awad, Michael J. Zuscik and Tao Wang. Their work appears in journals such as Advanced Materials, Journal of Clinical Investigation and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026